The Workbench · Craft
Hong Kong's device listing is voluntary; procurement isn't
This blog has already covered how New Zealand's WAND logs a device for safety monitoring without Medsafe ever reviewing it, and how Israel's AMAR skips its own review only when a foreign approval already covers the gap. Hong Kong's system goes a step further than either. There's no ordinance behind the log at all. The Medical Device Administrative Control System (MDACS), run by the Department of Health's Medical Device Division, lists a device only because the company applying chose to apply — and until this year, that was true no matter who was buying.
A scheme, not a statute
Hong Kong has never passed a dedicated medical device ordinance. Pharmaceuticals clear the Pharmacy and Poisons Ordinance; devices don't have an equivalent law requiring premarket approval, or even premarket notice, before they're sold. MDACS exists instead as an administrative scheme the Department of Health set up in 2004, described from the start as a transitional arrangement rather than a stand-in for legislation. Two decades on, it's still the only framework there is, and it's still voluntary.
The same four classes, doing a different job
MDACS sorts devices into the same ascending four-class system — Class I through IV — that GHTF-based regimes elsewhere use, and the classification itself looks familiar to anyone who's worked a 510(k) or a CE file. What's different is what a listing decision actually certifies. Entering a device, a Local Responsible Person, or a manufacturer, importer, or distributor into the Department's Medical Device Information System records that the applicant made specific representations about it. It isn't a reviewer signing off that the device may now be sold, because nothing in Hong Kong law asks the Department to make that call.
Nothing stops an unlisted device from reaching the market
A company can sell a device in Hong Kong's private market having never touched MDACS, and that's lawful, not a gap being quietly tolerated. What an unlisted device forgoes is the one credential a hospital, distributor, or tender evaluator can point to — a line in a government system naming the device, its class, and the party standing behind it. For most of MDACS's history, the absence of that credential never became a legal problem, because nothing required it for anyone.
One buyer just closed that gap for itself
Since 23 March 2026, the Department of Health's own procurement rules require that medical devices it buys be MDACS-listed before they can be supplied. That's a sourcing condition set by Hong Kong's own largest public healthcare purchaser, not a change to the underlying law — MDACS is still voluntary for the market as a whole. A device can be fully unlisted and legally sold to every private clinic and pharmacy in the territory while still being ineligible for a Department of Health tender until someone lists it.
A statutory version is still a proposal, not a law
Hong Kong's government has discussed replacing the voluntary scheme with real legislation for years, most recently as part of a planned Centre for Medical Products Regulation covering both drugs and devices. As of this writing that remains a legislative proposal moving through government channels, not a device law already in force — a tracker that logs Hong Kong as having a mandatory registration regime, on the strength of that plan, is logging something that hasn't happened yet.
Where this meets the file
A Hong Kong row in a cross-border tracker needs listing status recorded as a commercial fact, not a legal one: whether the device sits in MDIS, and separately, whether that listing is actually required for the specific channel the device is sold through — a Department of Health tender now needs it; a private-market sale still doesn't. A registration tracker built to carry that distinction, alongside the launch catalog's other cross-border templates, is previewed there now. If your program tracks Hong Kong differently, the shelf takes that correction directly.
The Regulatory Toolkit launches soon — a free shelf of source-mapped templates, checklists and browser-only tools for regulatory teams. Get one email when it opens, or contribute a template.